Search the Newsreel

CareDx (CDNA) insider Peter Maag files to sell 7,000 NASDAQ-listed shares

CareDx, Inc. insider Peter Maag has filed a notice to sell 7,000 shares of common stock, valued at $328,237.70, through Morgan Stanley Smith Barney LLC. These shares originated from restricted stock awards in late 2023 and early 2024. The filing also disclosed recent sales …

Baron Discovery Fund Gains from Strategic Accumulation of CareDx (CDNA)

The Baron Discovery Fund increased its position in CareDx (CDNA) after shares declined in Q3 2025 due to a draft local coverage decision by CMS that threatened reimbursement for its diagnostic tests. The fund believed the stock was undervalued at $11-12, representing a worst-case …

MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal

MiMedx Group has clarified the termination fees for its merger with Sanara MedTech Inc., stating Sanara would owe $9.66 million in specific cases and MiMedx $22.54 million if it fails to close. The deal offers Sanara shareholders $33.00 cash plus 0.4735 shares of MiMedx …

Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees

Sanara MedTech Inc. has confirmed the terms of its merger with MiMedx Group, Inc., where each Sanara share will convert into $33.00 in cash and 0.4735 shares of MiMedx common stock, valued at $2.00 per share. This amendment also corrects previously misstated termination fees, …

GeneDx Holdings (WGS) Is Up 14.8% After Loss-Making Q2, New Capital Raise And Guidance Reaffirmation

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

New offering integrates virtual clinicians to create a scalable channel to increase availability of GeneDx exome testing for eligible children facing specialty-care barriers GAITHERSBURG, Md., August 11, 2026--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of …

CareDx (CDNA) Trades 68% Above Fair Value Following Strong Q2 And Raised Guidance

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 7, 2026

CareDx, Inc. announced inducement grants of restricted stock units (RSUs) to 35 new employees as a material incentive for their employment. A total of 97,090 shares of common stock were awarded, with most RSUs vesting over four years and one employee's RSUs vesting 100% …

MiMedx Group, Inc Revenue Breakdown – NASDAQ:MDXG

This article provides a revenue breakdown for MiMedx Group, Inc (NASDAQ: MDXG). Last year, the company generated $418.63 million USD in total revenue, with its Wound segment being the top performer, contributing $276.33 million USD. The United States was the greatest regional contributor to …

This Insider Has Just Sold Shares In CareDx

CareDx's Independent Chairman, Michael Goldberg, recently sold US$2.1m worth of shares, reducing his total holding by 24%. While this is the largest insider sale in the past year, the shares were sold at a price close to the current market value. Despite no insider …

MiMedx Group Inc (MDXG) Stock News Today

This article from TradingKey provides current stock information for MiMedx Group Inc (MDXG), including its stock price, market cap, and P/E ratio. It notes that more news regarding MDXG's earnings, analyst ratings, and key developments will be available soon. The page serves as a …

MiMedx (MDXG) Q2 2026 Earnings Call Transcript

GeneDx Holdings (WGS) Is Up 18.4% After Reaffirming 2026 Outlook And Raising Equity From Blackstone

In early August 2026, GeneDx Holdings Corp. reported second-quarter revenue of US$114.44 million with a net loss of US$17.74 million, reaffirmed its full-year 2026 revenue outlook, and announced a private placement of 81,967 Class A shares at US$61.00 each with participation from a Blackstone …

State Street (CDNA holder) discloses 2.47M CareDx shares under shared control

State Street Corporation has reported a beneficial ownership of 2,468,858 shares of CareDx, Inc. common stock, which represents 4.8% of the class, according to a Schedule 13G SEC filing. All voting and dispositive authority for these shares is shared through affiliated investment adviser entities. …

WGS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Faruqi & Faruqi, LLP is investigating potential claims against GeneDx Holdings Corp. (NASDAQ: WGS) and reminds investors of the August 3, 2026 deadline to seek lead plaintiff status in a federal securities class action lawsuit. The lawsuit alleges that GeneDx and its executives made …

CareDx (CDNA): Neil Gagnon and Gagnon entities report 4.4% ownership stake

Neil Gagnon and his affiliated entities, Gagnon Securities LLC and Gagnon Advisors, LLC, have reported a collective ownership stake of 4.4% in CareDx, Inc. (CDNA) common stock through a SCHEDULE 13G/A SEC filing. Neil Gagnon individually beneficially owns 2,293,464 shares (4.4%), while Gagnon Securities …

CareDx (NASDAQ: CDNA) insider Peter Maag plans 27,332-share stock sale after option exercise

CareDx, Inc. insider Peter Maag has filed to sell 27,332 shares of Common Stock, which are tied to a stock option exercise dated August 7, 2026. The sale will be executed on NASDAQ through Morgan Stanley Smith Barney LLC’s Executive Financial Services program. The …

CareDx Inc (CDNA) Stock News Today

Statutory Earnings May Not Be The Best Way To Understand CareDx's (NASDAQ:CDNA) True Position

CareDx's recent strong earnings report, while positive on the surface, may not fully reflect the company's underlying financial health. The analysis highlights a high accrual ratio of 0.28, indicating that free cash flow significantly lagged statutory profit, partly due to a US$109m boost from …

Janus Henderson Group PLC Has $5.50 Million Stock Position in CareDx, Inc. $CDNA

Janus Henderson Group PLC has increased its stake in CareDx, Inc. (NASDAQ:CDNA) by 10.1% to 316,519 shares, valued at approximately $5.5 million. This comes as CareDx reported stronger-than-expected quarterly earnings with $0.37 EPS and revenue of $131.95 million, a 52.2% year-over-year increase. Despite a …

CareDx (NASDAQ:CDNA) Is Posting Healthy Earnings, But It Is Not All Good News

CareDx, Inc. (CDNA) Stock Analysis: Strong Revenue Growth and Investor Optimism Signal Potential Upside

CareDx, Inc. (CDNA) insider sells 2,688 shares under trading plan

CareDx, Inc. Secretary and General Counsel Jeffrey Adam Novack sold 2,688 shares of common stock on August 5, 2026, under a Rule 10b5-1 trading plan established in September 2025. The sales were executed in two tranches at weighted average prices of $46.1492 and $46.75 …

Dimensional Fund Advisors LP Has $25.38 Million Stock Position in CareDx, Inc. $CDNA

Dimensional Fund Advisors LP significantly increased its stake in CareDx, Inc. by 11.6% in the first quarter, now holding 1.46 million shares valued at $25.38 million. This comes as CareDx reported stronger-than-expected quarterly earnings and revenue. Despite mixed analyst ratings and recent insider stock …

CareDx, Inc. (CDNA) director sells 16,000 shares in planned trade

CareDx, Inc. director Christine Cournoyer sold 16,000 shares of common stock on August 4, 2026, under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $46.9358 per share, ranging from $46.25 to $47.2250, leaving her with 42,943 shares. …

GeneDx to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., August 06, 2026--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in upcoming investor conferences: Canaccord Genuity 46th Annual Growth Conference Boston, MA Fireside Chat: …

CareDx, Inc. SEC Filing (Aug 5, 2026)

This article details a CareDx, Inc. (CDNA) SEC Filing on Form 144, dated August 5, 2026. The filing indicates a proposed sale of 20,000 shares of common stock by an individual who acquired them as compensation for past services in 2015, with an aggregate …

MiMedx Group's (NASDAQ:MDXG) Soft Earnings Are Actually Better Than They Appear

MiMedx Group's recent earnings might seem weak, but a deeper analysis reveals a stronger financial position than initially perceived. The company's accrual ratio of -0.36 indicates that its free cash flow significantly exceeded its reported statutory profit, suggesting an understatement of its true earnings …

MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for MiMedx Group Inc (MDXG), highlighting its current earnings forecast score of 8.00 and an average analyst price target of $12.00. Based on 5 analysts, the stock has a "Buy" rating with a potential upside of 61.29%. Key …

GeneDx Holdings Corp. (NASDAQ:WGS) Analysts Are Pretty Bullish On The Stock After Recent Results

Analysts are showing increased optimism for GeneDx Holdings Corp. (NASDAQ:WGS) after its latest second-quarter results, which saw revenues beat expectations and statutory losses narrow more than anticipated. Although revenue forecasts remain unchanged for the coming year, analysts have revised their loss per share predictions, …

GeneDx (WGS) Stock Climbs On Strong Margins As Reimbursement Lags

GeneDx Holdings Corp. (WGS) saw its stock climb 4.8% after reporting strong Q2 2026 results, with exome and genome revenue reaching US$100.3 million and a gross margin of around 70%. The company achieved adjusted profitability ahead of schedule, demonstrating its core engine's efficiency. However, …

Planned 46,963-share sale reported by CDNA insider (CDNA)

A Form 144 notice for CareDx, Inc. (CDNA) indicates a proposed sale of up to 46,963 shares of common stock, valued at $2,178,945.34 as of August 5, 2026, through Morgan Stanley Smith Barney LLC. These shares originate from restricted stock grants and a stock …

Price to sales forward of CareDx, Inc. – LS:A118WG

This article provides financial information for CareDx, Inc. (A118WG) from TradingView, focusing on its price to sales forward metric. It indicates that no trades were recorded and the market was closed. The content is primarily a data page with various links to other financial …